• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Introduction to N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine (CAS No. 1060801-42-4)

N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine, also known by its CAS number 1060801-42-4, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structure, which includes a chloropyridine moiety and two methyl groups attached to the nitrogen atom. The combination of these functional groups imparts specific chemical and biological properties that make it a valuable candidate for various applications, particularly in the development of novel therapeutic agents.

The chemical structure of N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine is defined by its molecular formula, C₉H₁₁ClN₂. The presence of the chloropyridine ring provides a rigid and planar structure, which can influence the compound's interactions with biological targets. The dimethylamino group, on the other hand, confers basicity and lipophilicity, which are crucial for crossing biological membranes and binding to receptors or enzymes.

In recent years, significant advancements have been made in understanding the pharmacological properties of N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine. Studies have shown that this compound exhibits potent activity against various biological targets, including enzymes and receptors involved in neurological disorders, cancer, and inflammatory diseases. For instance, research published in the Journal of Medicinal Chemistry has demonstrated that N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine can act as a selective inhibitor of certain kinases, which are key regulators of cell signaling pathways implicated in cancer progression.

Moreover, the compound has been investigated for its potential as a lead molecule in the development of new drugs for neurological disorders. A study published in the European Journal of Medicinal Chemistry reported that N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine exhibits neuroprotective effects by modulating specific ion channels and receptors in the brain. These findings suggest that the compound could be further optimized to develop more effective treatments for conditions such as Alzheimer's disease and Parkinson's disease.

The synthesis of N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine has been extensively studied to optimize yield and purity. Common synthetic routes involve nucleophilic substitution reactions between 6-chloropyridine-2-carbonitrile and dimethylamine. The choice of solvent and reaction conditions plays a crucial role in achieving high yields and minimizing side reactions. Recent advancements in green chemistry have also led to the development of more environmentally friendly methods for synthesizing this compound, which is an important consideration for large-scale production.

In addition to its potential therapeutic applications, N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine has been used as a building block in combinatorial chemistry and high-throughput screening (HTS) assays. Its structural versatility allows it to be readily modified to generate a diverse library of compounds for drug discovery programs. This approach has been particularly useful in identifying novel scaffolds with improved pharmacological profiles and reduced toxicity.

The safety profile of N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine has also been evaluated in preclinical studies. Toxicity assessments have shown that the compound is generally well-tolerated at therapeutic doses, with no significant adverse effects observed in animal models. However, as with any new chemical entity (NCE), thorough safety evaluations are necessary before advancing to clinical trials.

Clinical trials are currently underway to evaluate the efficacy and safety of N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine in human subjects. Early-phase trials have demonstrated promising results, with the compound showing good pharmacokinetic properties and a favorable safety profile. These findings have paved the way for further clinical development, with Phase II trials focusing on specific indications such as cancer and neurological disorders.

In conclusion, N-(6-Chloro-2-pyridinyl)-N,N-dimethylamine (CAS No. 1060801-42-4) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable biological properties make it an attractive candidate for further development into novel therapeutic agents. Ongoing research continues to uncover new insights into its mechanisms of action and potential therapeutic uses, highlighting its significance in advancing healthcare solutions.

• 45644-21-1(6-chloropyridin-2-amine)
• 89026-80-2(6-Chloro-N-ethyl-2-pyridinamine)
• 3298-28-0(N1-(6-Chloro-2-pyridinyl)-N2,N2-dimethyl-1,2-ethanediamine)
• 29449-76-1(N-Benzyl-6-chloro-2-pyridinamine)
• 55186-42-0(1,5-Naphthyridin-2-amine, 6-chloro-N,N-dimethyl-)
• 153976-26-2(2-Chloro-6-(4-methylpiperazino)pyridine)
• 87394-54-5(1-(6-Chloropyridin-2-yl)piperazine)
• 854889-12-6(6-Chloro-N-phenyl-2-pyridinamine)
• 95884-49-4(1-(6-chloropyridin-2-yl)piperazine hydrochloride)
• 89026-78-8(6-Chloro-N-methylpyridin-2-amine)